norovirus

BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it will present at the 2023 Cantor Global…

As the world emerges from the pandemic, the cruise industry is experiencing a resurgence in demand. While last summer's departures offered generous elbow room for passengers, this year tells a different story. Cruise lines reported…

Elana Gotkine MONDAY, June 5, 2023 (HealthDay News) -- Foodborne illness outbreaks most commonly involve norovirus, according to research published in the June 2 issue of the U.S. Centers for…

Every year, norovirus causes hundreds of millions of cases of food poisoning -- and the deaths of at least 50,000 children -- yet there exists no real way to control it. The virus has proven exceptionally difficult to study in the lab, and…

NHS England has warned that the health service is coming under growing pressure from a 50% increase in norovirus cases in recent weeks. The bug can cause vomiting, stomach upset and diarrhoea and can be especially problematic for people…

<!-- Name:DistributionId Value:8790320 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

<!-- Name:DistributionId Value:8748472 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

A new study may have solved a mystery surrounding Crohn's disease, an inflammatory bowel illness where immune defenses, meant to attack invading microbes, instead mistakenly target the body's own digestive tract. Norovirus, a common…

Physician’s Briefing Staff THURSDAY, Sept. 22, 2022 (HealthDay News) -- The number of norovirus outbreaks increased in the 2021 to 2022 surveillance year, returning to levels similar to prepandemic…

Enrollment of remaining subjects in NEST-IN1 has resumed Immunogenicity results from the first 200 subjects expected in Q4 2022 BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage…